Who
Malcolm Hoenlein
Director
Company insider
Files Form 4 as: Director, Fortress Biotech; Director, DarioHealth; Director, PureSafe Water Systems; Director and Other, TG Therapeutics; Director, Keryx Biopharmaceuticals.
In numbers
- Trades disclosed
- 48
- Buys
- 2
- Sells
- 1
- Bought
- $340K
- Sold
- $93K
- Companies
- 5
- Companies where not an officer
- 5
- First trade
- 9 Jun 2006
- Last trade
- 1 Jan 2026
- Last filed
- 5 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jan 2026filed 5 Jan 2026 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Code A | —27,322 at $0.00 | filing |
| 1 Jan 2026filed 5 Jan 2026 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Code A | —27,322 at $0.00 | filing |
| 1 Jan 2025filed 3 Jan 2025 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Code A | —49,383 at $0.00 | filing |
| 1 Jan 2024filed 3 Jan 2024 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Code A | —3,333 at $0.00 | filing |
| 1 Jan 2023filed 4 Jan 2023 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 1 Jan 2022filed 29 Apr 2022 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 16 Nov 2021filed 29 Apr 2022 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Code J | —230 at $0.00 | filing |
| 30 Sep 2021filed 29 Apr 2022 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Code J | —406 at $0.00 | filing |
| 1 Jan 2021filed 9 Apr 2021 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 26 Aug 2020filed 1 Sep 2020 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Bought | $300K16,667 at $18.00 | filing |
| 1 Jan 2020filed 13 Mar 2020 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 1 Jan 2019filed 12 Apr 2019 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 6 Jun 2018filed 8 Jun 2018 | DRIO DarioHealthMedical Devices | SEC FORM 4 Code A | —24,353 at $0.00 | filing |
| 23 Apr 2018filed 25 Apr 2018 | DRIO DarioHealthMedical Devices | SEC FORM 4 Code A | —6,653 at $0.00 | filing |
| 4 Jan 2018filed 8 Jan 2018 | DRIO DarioHealthMedical Devices | SEC FORM 4 Code A | —6,531 at $0.00 | filing |
| 1 Jan 2018filed 30 Nov 2018 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 23 Oct 2017filed 25 Oct 2017 | DRIO DarioHealthMedical Devices | SEC FORM 4 Code A | —5,521 at $0.00 | filing |
| 10 Jul 2017filed 11 Jul 2017 | DRIO DarioHealthMedical Devices | SEC FORM 4 Code A | —4,433 at $0.00 | filing |
| 13 Apr 2017filed 17 Apr 2017 | DRIO DarioHealthMedical Devices | SEC FORM 4 Code A | —2,800 at $0.00 | filing |
| 10 Mar 2017filed 21 Jul 2017 | FBIO Fortress Biotechoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,666 at $0.00 | filing |
News
Head to Head Analysis: Fortress Biotech (NASDAQ:FBIO) versus 60 Degrees Pharmaceuticals (NASDAQ:SXTP)FBIO · tickerreport.com · 17 Oct 2026Critical Survey: Fortress Biotech (NASDAQ:FBIO) vs. 60 Degrees Pharmaceuticals (NASDAQ:SXTP)FBIO · tickerreport.com · 11 Oct 2026
0 headlines in the last 90 days name Malcolm Hoenlein; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.